Transdermal Drug Delivery Systems Market - By Type (Transdermal Patches and Transdermal Semisolids), By Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases), By End User (Home Care Settings And Hospitals & Clinics) And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 193
Status: Published
Report Code: ARI100588
The efficacious nature of these devices can be attributed to the heightened drug diffusion capabilities over conventional routes of drug delivery, namely oral, intravenous, and pulmonary. Additionally, a significant contributor to market growth is the increasing inclination of patients as well as physicians toward pain-free drug delivery, which is further presumed to drive the market demand over the forecast period. These aforementioned factors are expected to widen the scope for growth throughout the forecast period.
Moreover, high demand for self-administration of drugs for diseases requiring long-term treatment, such as in patients with diabetes, is providing a boost to this market. In the case of diabetes, insulin has to be administered into the patient's body with the help of injections in a continual manner. The frequent use of injections to deliver insulin causes pain and increase the risk of infection transmission. The rising patient preference for pain-free drug administration has led to a significant surge in the adoption rate of adhesive skin patches that administer drugs, which is anticipated to present the market with high growth potential. In addition, the incorporation of transdermal systems will promote self-reliance in patients through a significant reduction in the frequency of hospital visits and cumulative treatment costs.
The emergence of technological innovations, such as the inclusion of microneedles or mechanical arrays in transdermal patches, is expected to provide the market with lucrative growth opportunities over the coming years. The advancements include modifications in transdermal patch designs, incorporation of pressure-sensitive adhesives, permeation enhancers, which have resulted in enhanced drug diffusion and increased capacity to hold a greater amount of drug in the reservoir. Moreover, other innovations comprise miniaturized and advanced transdermal patches and reservoir type transdermal patches, which deliver accurate medication dosage.
The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), and GlaxoSmithKline (UK). Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).
Hisamitsu is a leading company in the field of drugs for external use. The company is a pioneer in the field of transdermal patches. The company markets its transdermal products in North America, Europe, Central & South America, Asia & Oceania, and the Middle East & Africa. The firm has constantly focused on research and development to enhance its transdermal products and launch them in the market. For instance, in 2017, the firm spent over USD 14.0 million compared to USD 12.8 million in 2016 on R&D activities.
Analyst Commentary
The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems.
Based on applications, in 2020, the pain management segment is expected to account for the largest share of the transdermal drug delivery systems market. The large share of this segment can be attributed to the high burden of chronic pain worldwide and the growing availability of transdermal products for pain management.
On the basis of type, the transdermal patches segment is also expected to grow at a higher rate during the forecast period. This can be attributed to the benefits offered by transdermal patches such as reduced dosing frequency, improved bioavailability, reduced adverse events, and drug input termination at any point by the removal of the patch
On the basis of end users, the home care settings segment is expected to grow at a higher CAGR during the forecast period. The high growth in this segment can be attributed to the increase in self-administration of medication at home, rapid growth in the geriatric population across the globe, and the growing need for cost-effective drug administration.
Segmentation
The global Transdermal Drug Delivery System Market is segmented on the basis of type, application, end user and region. On the basis of type, the transdermal drug delivery systems market is segmented into transdermal patches and transdermal semisolids. On the basis of end users, the transdermal drug delivery systems market is segmented into home care settings and hospitals & clinics. On the basis of application, the market is bifurcated into Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, and Other Applications.
Regional Analysis
Geographically, the global transdermal drug delivery market is segmented into North America, Europe, Asia Pacific and Rest of the World. Nicotine patch is highly sold in the United States. This patch releases nicotine in controlled manner to help with the cessation of tobacco smoking. In Europe, the first commercially available vapour patch was approved in 2007 to reduce smoking habits. Transdermal patches are gaining share in the global transdermal drug delivery market penetration because primary care physicians and patients equally put more emphasis on easy-to-use drug delivery methods
North America captured a sizeable share. The growth in this region is majorly driven by patent expirations, resulting in more companies entering the market. In addition, reformulation of existing drug compounds, repositioning of previously failed drugs, and huge investments undertaken by prominent as well as new market entrants are also presumed to be key factors responsible for the substantial share captured by this region.
The Asia Pacific market is anticipated to exhibit the fastest CAGR during the forecast period, which is attributable to the growing healthcare spending and the rapidly evolving healthcare infrastructure. In addition, the growth is due to the high research and development intensity as well as the growing awareness in the emerging economies, such as China and India.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Transdermal Drug Delivery System Market
Chapter 5. Global Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
5.1. Global Transdermal Drug Delivery System Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. Transdermal Patches
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Transdermal semisolids
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027(USD Million)
6.1. Global Transdermal Drug Delivery System Market Share, By Application, 2015 - 2027 (USD Million)
6.1.1. Pain management
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Hormonal Applications
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Central Nervous System Disorders
6.1.3.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Others
6.1.4.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Transdermal Drug Delivery System Market Overview, By End-users, 2015 - 2027(USD Million)
7.1. Global Transdermal Drug Delivery System Market Share, By End-users, 2015 - 2027 (USD Million)
7.1.1. Care Settings
7.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Hospitals & Clinics
7.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Transdermal Drug Delivery System Market Overview, By Geography, 2015 - 2027(USD Million)
8.1. Global Transdermal Drug Delivery System Market Share, By Geography, 2015 - 2027(USD Million)
8.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Transdermal Drug Delivery System Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. North America Transdermal Drug Delivery System Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.2. North America Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. North America Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4. North America Transdermal Drug Delivery System Market Overview, By End-users, 2015 - 2027 (USD Million)
9.1.5. North America Transdermal Drug Delivery System Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.5.1. U.S. Transdermal Drug Delivery System Market Overview, 2015 - 2027 (USD Million)
9.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.1.2. U.S. Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Transdermal Drug Delivery System Market Overview, 2015 - 2027 (USD Million)
9.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.2.2. Canada Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Transdermal Drug Delivery System Market Overview, 2015 - 2027 (USD Million)
9.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.5.3.2. Mexico Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Transdermal Drug Delivery System Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. Europe Transdermal Drug Delivery System Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.2. Europe Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Europe Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4. Europe Transdermal Drug Delivery System Market Overview, By End-users,2015 - 2027 (USD Million)
10.1.5. Europe Skin Care Types Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.1.2. Germany Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.1.3. Germany Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.2.2. France Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.2.3. France Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.3.2. UK Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.3.3. UK Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.4.2. Italy Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.4.3. Italy Transdermal Drug Delivery System Market Overview, By Application 2015 - 2027(USD Million)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.5.5.2. Spain Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.5.3. Spain Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Type and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
10.1.5.6.3. Rest of Europe Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027(USD Million)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Transdermal Drug Delivery System Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Transdermal Drug Delivery System Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Transdermal Drug Delivery System Market Overview, By End-users,2015 - 2027 (USD Million)
11.1.5. Asia Pacific Transdermal Drug Delivery System Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.1.2. India Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.1.3. India Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Type and projections, 2015 - 2027(USD Million)
11.1.5.2.2. China Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.2.3. China Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.3.2. Japan Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.3.3. Japan Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027(USD Million)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Type and projections, 2015 - 2027(USD Million)
11.1.5.4.2. South Korea Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.4.3. South Korea Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027(USD Million)
11.1.5.5.3. Rest of Asia Pacific Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Transdermal Drug Delivery System Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Transdermal Drug Delivery System Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Transdermal Drug Delivery System Market Overview, By End-users,2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Transdermal Drug Delivery System Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.1.2. GCC Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.1.3. GCC Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.2.2. South Africa Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.2.3. South Africa Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.5.3.4. Other Segments
Chapter 13. South America Transdermal Drug Delivery System Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Transdermal Drug Delivery System Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.2. South America Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.3. South America Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.4. South America Transdermal Drug Delivery System Market Overview, By End-users,2015 - 2027 (USD Million)
13.1.5. South America Transdermal Drug Delivery System Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.6.2. Brazil Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.6.3. Brazil Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Type and projections, 2015 - 2027 (USD Million)
13.1.7.2. Argentina Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.7.3. Argentina Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Type and projections, 2015 – 2027
13.1.8.2. Rest of South America Transdermal Drug Delivery System Market Overview, By Type, 2015 - 2027 (USD Million)
13.1.8.3. Rest of South America Transdermal Drug Delivery System Market Overview, By Application, 2015 - 2027 (USD Million)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Type development
Chapter 15. Key Vendor Analysis
15.1. Hisamitsu Pharmaceutical
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Mylan
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. UCB
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. Novartis
15.5. GLAXOSMITHKLINE
15.6. Boehringer Ingelheim
15.7. JOHNSON & JOHNSON
15.8. Purdue Pharma
Chapter 16. Transdermal Drug Delivery System Market Cost Analysis
16.1. Transdermal Drug Delivery System Market Key Type Analysis
16.1.1. Key Type
16.1.2. Price Trend of Key Type
16.1.3. Key Suppliers of Type
16.1.4. Market Concentration Rate of Type
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Transdermal Drug Delivery System Market Chain Analysis
17.2. Upstream Type Sourcing
17.3. Transdermal Drug Delivery System Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Type
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Transdermal Drug Delivery System Market share, By Type, 2020 & 2027 (%)
10. Global Transdermal Drug Delivery System Market share, by Transdermal Patches, By Type, 2015 - 2027 (USD Million)
11. Global Transdermal Drug Delivery System Market share, by Transdermal semisolids, By Type, 2015 - 2027 (USD Million)
12. Global Transdermal Drug Delivery System Market share, By Application, 2020 & 2027 (%)
13. Global Transdermal Drug Delivery System Market share, by Pain management, By Application, 2015 - 2027 (USD Million)
14. Global Transdermal Drug Delivery System Market share, by Hormonal Applications, By Application 2015 - 2027 (USD Million)
15. Global Transdermal Drug Delivery System Market share, by Central Nervous System Disorders, By Application 2015 - 2027 (USD Million)
16. Global Transdermal Drug Delivery System Market share, by Others, By Application 2015 - 2027 (USD Million)
17. Global Transdermal Drug Delivery System Market share, By End-users, 2020 & 2027 (%)
18. Global Transdermal Drug Delivery System Market share, by Care Settings, By End-users, 2015 - 2027 (USD Million)
19. Global Transdermal Drug Delivery System Market share, by Hospitals & Clinics, By End-users 2015 - 2027 (USD Million)
20. Global Transdermal Drug Delivery System Market share, by region, 2020 & 2027 (%)
21. Global Transdermal Drug Delivery System Market share, by region, 2015 - 2027(USD Million)
22. North America Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
23. North America Transdermal Drug Delivery System Market share, by Countries, 2020 & 2027 (%)
24. U.S. Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
25. Canada Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
26. Mexico Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
27. Europe Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
28. Europe Transdermal Drug Delivery System Market share, by Countries, 2020 & 2027 (%)
29. Spain Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
30. UK Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
31. Italy Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
32. Germany Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
33. France Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
34. Rest of Europe Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
35. Asia-Pacific Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
36. Asia-Pacific Transdermal Drug Delivery System Market share, by Countries, 2020 & 2027 (%)
37. China Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
38. India Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
39. Australia Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
40. Japan Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
41. Rest of Asia-Pacific Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
42. Middle East & Africa Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
43. Middle East & Africa Transdermal Drug Delivery System Market share, by Countries, 2020 & 2027 (%)
44. GCC Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
45. South Africa Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
46. Rest Of Middle East & Africa Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
47. South America Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
48. Brazil Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
49. Mexico Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
50. Argentina Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
51. Rest Of South America Transdermal Drug Delivery System Market, 2015 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Transdermal Drug Delivery System Market, 2015-2027 (USD Million)
4. Transdermal Drug Delivery System requirement, by country, 2015-2027, (USD Million)
5. North America Transdermal Drug Delivery System Market, By Type, 2015-2027 (USD Million)
6. North America Transdermal Drug Delivery System Market, By Application, 2015-2027 (USD Million)
7. North America Transdermal Drug Delivery System Market, By End-users, 2015-2027 (USD Million)
8. Europe Transdermal Drug Delivery System Market, By Type, 2015-2027 (USD Million)
9. Europe Transdermal Drug Delivery System Market, By Application, 2015-2027 (USD Million)
10. Europe Transdermal Drug Delivery System Market, By End-users, 2015-2027 (USD Million)
11. Asia Pacific Transdermal Drug Delivery System Market, By Type, 2015-2027 (USD Million)
12. Asia Pacific Transdermal Drug Delivery System Market, By Application, 2015-2027 (Revenue, USD Million)
13. Asia Pacific Transdermal Drug Delivery System Market, By End-users, 2015-2027 (Revenue, USD Million)
14. Middle East & Africa Transdermal Drug Delivery System Market, By Type, 2015-2027 (USD Million)
15. Middle East & Africa Transdermal Drug Delivery System Market, By Application, 2015-2027 (USD Million)
16. Middle East & Africa Transdermal Drug Delivery System Market, By End-users, 2015-2027 (USD Million)
17. South America Transdermal Drug Delivery System Market, By Type, 2015-2027 (USD Million)
18. South America Transdermal Drug Delivery System Market, By Application, 2015-2027 (USD Million)
19. South America Transdermal Drug Delivery System Market, By End-users, 2015-2027 (USD Million)
20. Global Transdermal Drug Delivery System Market, Company Market Share, 2020 - 2027 (%)
21. Hisamitsu Pharmaceutical : Deployment model Benchmarking
22. Hisamitsu Pharmaceutical : Financial Performance
23. Mylan : Deployment model Benchmarking
24. Mylan : Financial Performance
25. UCB: Deployment model Benchmarking
26. UCB : Financial Performance
27. Novartis: Deployment model Benchmarking
28. Novartis: Financial Performance
29. GLAXOSMITHKLINE :Deployment model Benchmarking
30. GLAXOSMITHKLINE : Financial Performance
31. Boehringer Ingelheim : Deployment model Benchmarking
32. Boehringer Ingelheim : Financial Performance
33. JOHNSON & JOHNSON : Product Benchmarking
34. JOHNSON & JOHNSON : Financial Performance
35. Purdue Pharma : Product Benchmarking
36. Purdue Pharma : Financial Performance
The Leading Key Players in Transdermal Drug Delivery Systems Market
Hisamitsu Pharmaceutical (Japan)
Mylan (US)
UCB (Belgium)
Novartis (Switzerland)
GlaxoSmithKline (UK). Boehringer Ingelheim (Germany)
Johnson & Johnson (US)
Endo International (Ireland)
Purdue Pharma (US).
